The EHA Research Roadmap: Malignant Lymphoid Diseases

Martin Dreyling (1) , Marc André , Nicola Gökbuget , Hervé Tilly , Mats Jerkeman , John Gribben , Andrés Ferreri , Pierre Morel , Stephan Stilgenbauer , Christopher Fox , José Maria Ribera , Sonja Zweegman , Igor Aurer , Csaba Bödör , Birgit Burkhardt , Christian Buske , Maria Dollores Caballero , Elias Campo , Bjoern Chapuy , Andrew Davies , Laurence de Leval , Jeanette Doorduijn , Massimo Federico , Philippe Gaulard , Francesca Gay , Paolo Ghia , Kirsten Grønbæk , Hartmut Goldschmidt , Marie-Jose Kersten , Barbara Kiesewetter , Judith Landman-Parker , Steven Le Gouill , Georg Lenz , Sirpa Leppä , Armando Lopez-Guillermo , Elizabeth Macintyre , Maria Victoria Mateos Mantega , Philippe Moreau , Carol Moreno , Bertrand Nadel (2) , Jessica Okosun , Roger Owen , Sarka Pospisilova , Christiane Pott , Tadeusz Robak , Michelle Spina , Kostas Stamatopoulos , Jan Stary , Karin Tarte , Allessandra Tedeschi , Catherine Thieblemont , Ralf Ulrich Trappe , Lorenz H Trümper , Gilles Salles (3, 4)

1 LMU Munich - Ludwig-Maximilians University Hospital
2 CIML - Centre d'Immunologie de Marseille - Luminy
3 Memorial Sloane Kettering Cancer Center [New York]
4 Weill Cornell Medicine [New York]

Domains: Life Sciences [q-bio]

Martin Dreyling, Marc André, Nicola Gökbuget, Hervé Tilly, Mats Jerkeman, et al.. The EHA Research Roadmap: Malignant Lymphoid Diseases. HemaSphere, 2022, 6, ⟨10.1097/hs9.0000000000000726⟩. ⟨hal-03952820⟩